130 related articles for article (PubMed ID: 28947977)
1. Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcoma.
Capone E; Piccolo E; Fichera I; Ciufici P; Barcaroli D; Sala A; De Laurenzi V; Iacobelli V; Iacobelli S; Sala G
Oncotarget; 2017 Sep; 8(36):60368-60377. PubMed ID: 28947977
[TBL] [Abstract][Full Text] [Related]
2. Anti-Endosialin Antibody-Drug Conjugate: Potential in Sarcoma and Other Malignancies.
Rouleau C; Gianolio DA; Smale R; Roth SD; Krumbholz R; Harper J; Munroe KJ; Green TL; Horten BC; Schmid SM; Teicher BA
Mol Cancer Ther; 2015 Sep; 14(9):2081-9. PubMed ID: 26184481
[TBL] [Abstract][Full Text] [Related]
3. Endosialin protein expression and therapeutic target potential in human solid tumors: sarcoma versus carcinoma.
Rouleau C; Curiel M; Weber W; Smale R; Kurtzberg L; Mascarello J; Berger C; Wallar G; Bagley R; Honma N; Hasegawa K; Ishida I; Kataoka S; Thurberg BL; Mehraein K; Horten B; Miller G; Teicher BA
Clin Cancer Res; 2008 Nov; 14(22):7223-36. PubMed ID: 19010839
[TBL] [Abstract][Full Text] [Related]
4. Tumour endothelial marker 1/endosialin-mediated targeting of human sarcoma.
Guo Y; Hu J; Wang Y; Peng X; Min J; Wang J; Matthaiou E; Cheng Y; Sun K; Tong X; Fan Y; Zhang PJ; Kandalaft LE; Irving M; Coukos G; Li C
Eur J Cancer; 2018 Feb; 90():111-121. PubMed ID: 29304474
[TBL] [Abstract][Full Text] [Related]
5. Endosialin: a novel malignant cell therapeutic target for neuroblastoma.
Rouleau C; Smale R; Sancho J; Fu YS; Kurtzberg L; Weber W; Kruger A; Jones C; Roth S; Bormann C; Dunham S; Krumbholz R; Curiel M; Wallar G; Mascarello J; Campos-Rivera J; Horten B; Schmid S; Miller G; Teicher BA
Int J Oncol; 2011 Oct; 39(4):841-51. PubMed ID: 21701770
[TBL] [Abstract][Full Text] [Related]
6. Endosialin is expressed in high grade and advanced sarcomas: evidence from clinical specimens and preclinical modeling.
Rouleau C; Smale R; Fu YS; Hui G; Wang F; Hutto E; Fogle R; Jones CM; Krumbholz R; Roth S; Curiel M; Ren Y; Bagley RG; Wallar G; Miller G; Schmid S; Horten B; Teicher BA
Int J Oncol; 2011 Jul; 39(1):73-89. PubMed ID: 21537839
[TBL] [Abstract][Full Text] [Related]
7. Endosialin/CD248 may be a potential therapeutic target to prevent the invasion and metastasis in osteosarcoma.
Kondo Y; Honoki K; Kishi S; Mori S; Fujiwara-Tani R; Tsukamoto S; Fujii H; Kuniyasu H; Tanaka Y
Oncol Lett; 2022 Feb; 23(2):42. PubMed ID: 34976154
[TBL] [Abstract][Full Text] [Related]
8. Characterization of TEM1/endosialin in human and murine brain tumors.
Carson-Walter EB; Winans BN; Whiteman MC; Liu Y; Jarvela S; Haapasalo H; Tyler BM; Huso DL; Johnson MD; Walter KA
BMC Cancer; 2009 Nov; 9():417. PubMed ID: 19948061
[TBL] [Abstract][Full Text] [Related]
9. Novel antibody probes for the characterization of endosialin/TEM-1.
O'Shannessy DJ; Smith MF; Somers EB; Jackson SM; Albone E; Tomkowicz B; Cheng X; Park Y; Fernando D; Milinichik A; Kline B; Fulton R; Oberoi P; Nicolaides NC
Oncotarget; 2016 Oct; 7(43):69420-69435. PubMed ID: 27494870
[TBL] [Abstract][Full Text] [Related]
10. Endosialin in Cancer: Expression Patterns, Mechanistic Insights, and Therapeutic Approaches.
Lu S; Gan L; Lu T; Zhang K; Zhang J; Wu X; Han D; Xu C; Liu S; Yang F; Qin W; Wen W
Theranostics; 2024; 14(1):379-391. PubMed ID: 38164138
[TBL] [Abstract][Full Text] [Related]
11. CD248: A therapeutic target in cancer and fibrotic diseases.
Teicher BA
Oncotarget; 2019 Jan; 10(9):993-1009. PubMed ID: 30847027
[TBL] [Abstract][Full Text] [Related]
12. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.
Tomkowicz B; Rybinski K; Foley B; Ebel W; Kline B; Routhier E; Sass P; Nicolaides NC; Grasso L; Zhou Y
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):17965-70. PubMed ID: 17986615
[TBL] [Abstract][Full Text] [Related]
13. Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.
Li C; Chacko AM; Hu J; Hasegawa K; Swails J; Grasso L; El-Deiry WS; Nicolaides N; Muzykantov VR; Divgi CR; Coukos G
Cancer Biol Ther; 2014 Apr; 15(4):443-51. PubMed ID: 24553243
[TBL] [Abstract][Full Text] [Related]
14. Design of Coltuximab Ravtansine, a CD19-Targeting Antibody-Drug Conjugate (ADC) for the Treatment of B-Cell Malignancies: Structure-Activity Relationships and Preclinical Evaluation.
Hong EE; Erickson H; Lutz RJ; Whiteman KR; Jones G; Kovtun Y; Blanc V; Lambert JM
Mol Pharm; 2015 Jun; 12(6):1703-16. PubMed ID: 25856201
[TBL] [Abstract][Full Text] [Related]
15. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis-related protein Mac-2 BP/90K.
Becker R; Lenter MC; Vollkommer T; Boos AM; Pfaff D; Augustin HG; Christian S
FASEB J; 2008 Aug; 22(8):3059-67. PubMed ID: 18490383
[TBL] [Abstract][Full Text] [Related]
16. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells.
Christian S; Winkler R; Helfrich I; Boos AM; Besemfelder E; Schadendorf D; Augustin HG
Am J Pathol; 2008 Feb; 172(2):486-94. PubMed ID: 18187565
[TBL] [Abstract][Full Text] [Related]
17. EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors.
Capone E; Lattanzio R; Gasparri F; Orsini P; Rossi C; Iacobelli V; De Laurenzi V; Natali PG; Valsasina B; Iacobelli S; Sala G
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33918158
[TBL] [Abstract][Full Text] [Related]
18. Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies.
O'Shannessy DJ; Dai H; Mitchell M; Huntsman S; Brantley S; Fenstermacher D; Reed DR
Sarcoma; 2016; 2016():5213628. PubMed ID: 27057137
[TBL] [Abstract][Full Text] [Related]
19. Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.
Junutula JR; Flagella KM; Graham RA; Parsons KL; Ha E; Raab H; Bhakta S; Nguyen T; Dugger DL; Li G; Mai E; Lewis Phillips GD; Hiraragi H; Fuji RN; Tibbitts J; Vandlen R; Spencer SD; Scheller RH; Polakis P; Sliwkowski MX
Clin Cancer Res; 2010 Oct; 16(19):4769-78. PubMed ID: 20805300
[TBL] [Abstract][Full Text] [Related]
20. Endosialin-Expressing Pericytes Promote Metastatic Dissemination.
Viski C; König C; Kijewska M; Mogler C; Isacke CM; Augustin HG
Cancer Res; 2016 Sep; 76(18):5313-25. PubMed ID: 27635044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
